Open AccessRituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study
Author(s) -
Michael Launspach,
Dennis Temel,
Emily Ohlendorf,
Felix Zirngibl,
Bianca Materne,
Lena Oevermann,
Hedwig E. Deubzer,
Anton G. Henssen,
Annette Künkele,
Patrick Hundsdörfer,
Horst von Bernuth,
Axel Pruß,
Angelika Eggert,
Arend von Stackelberg,
Peter Lang,
Johannes H. Schulte
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.281134
Subject(s) - medicine , hematopoietic stem cell transplantation , rituximab , retrospective cohort study , stem cell , transplantation , oncology , cohort , hematopoietic cell , haematopoiesis , immunology , lymphoma , biology , genetics